Page last updated: 2024-08-18

captan and chromium

captan has been researched along with chromium in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Harris, MA; Haws, LC; Kirman, CR; McCoy, A; Proctor, DM; Suh, M; Thompson, CM; Wolf, JC1
Babic, M; Chappell, GA; Harris, MA; LeBlanc, KJ; Rager, JE; Ring, CL; Thompson, CM; Wolf, J1
Bhat, VS; Cohen, SM; Cullen, JM; Gordon, EB; Harris, MA; Proctor, DM; Thompson, CM; Wood, CE1

Reviews

1 review(s) available for captan and chromium

ArticleYear
An adverse outcome pathway for small intestinal tumors in mice involving chronic cytotoxicity and regenerative hyperplasia: a case study with hexavalent chromium, captan, and folpet.
    Critical reviews in toxicology, 2020, Volume: 50, Issue:8

    Topics: Adverse Outcome Pathways; Animals; Captan; Chromium; Duodenum; Fungicides, Industrial; Humans; Hyperplasia; Intestinal Neoplasms; Mice; Phthalimides; Risk Assessment

2020

Other Studies

2 other study(ies) available for captan and chromium

ArticleYear
Comparison of Toxicity and Recovery in the Duodenum of B6C3F1 Mice Following Treatment with Intestinal Carcinogens Captan, Folpet, and Hexavalent Chromium.
    Toxicologic pathology, 2017, Volume: 45, Issue:8

    Topics: Administration, Oral; Animals; Captan; Carcinogens; Chromium; Dose-Response Relationship, Drug; Duodenum; Female; Intestinal Mucosa; Mice, Inbred Strains; Phthalimides

2017
Comparison of Gene Expression Responses in the Small Intestine of Mice Following Exposure to 3 Carcinogens Using the S1500+ Gene Set Informs a Potential Common Adverse Outcome Pathway.
    Toxicologic pathology, 2019, Volume: 47, Issue:7

    Topics: Animals; Captan; Carcinogens; Chromium; Gene Expression Profiling; Hypoxia-Inducible Factor 1, alpha Subunit; Intestine, Small; Mice; Phthalimides

2019